This could increase the risk of acquiring fusion genes, such as the TMPRSS2/ERG fusion that is found in 40-50% of PCa cases [35], although no solid evidence has been acquired to link BRCA1/2 mutation status to this fusion. This evidence concerns the gene BRCA1 and posterior cortical atrophy.